KRT8P9: A Potential Drug Target and Biomarker (G390601)

Target Name: KRT8P9

NCBI ID: G390601

KRT8P9

Other Name(s): keratin 8 pseudogene 9 | Keratin 8 pseudogene 9

KRT8P9: A Potential Drug Target and Biomarker

Keratin is a protein that is found in the hair, nails, and skin. It is made up of several different genes, including KRT8P9. KRT8P9 is a pseudogene, which means that it is a genetic sequence that is present in the DNA but does not code for any functional protein. However, recent studies have shown that KRT8P9 is involved in several important biological processes, including the development and maintenance of hair and nails.

One of the interesting aspects of KRT8P9 is its potential as a drug target. By interacting with KRT8P9, drugs could potentially inhibit the growth of cancer cells or slow down their growth. This could be useful for treating a variety of diseases, including cancer.

Another potential use of KRT8P9 as a drug target is its role as a biomarker. By analyzing the levels of KRT8P9 in cancer cells, doctors could potentially determine the effectiveness of a given treatment. This could be a useful tool for monitoring the effectiveness of cancer treatments and identifying potential side effects.

In addition to its potential as a drug target and biomarker, KRT8P9 is also of interest to researchers because of its unique genetic sequence. Unlike many other genes, KRT8P9 is completely conserved across species, which means that it is likely to have a similar structure and function across different species. This makes it an ideal candidate for studies of gene function and the consequences of genetic variation.

Overall, KRT8P9 is a fascinating protein that has the potential to be a drug target and biomarker. Further research is needed to fully understand its role in these important biological processes.

Protein Name: Keratin 8 Pseudogene 9

The "KRT8P9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT8P9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets